Biomarkers · Inflammation
Serum Ferritin
Lower values go with lower risk of death. In NHANES 1999–2018 with linked mortality to 2019, each standard deviation above average goes with 9% higher risk of death. We found the same pattern in NHANES
Serum Ferritin and risk of death
Published curve higher than the NHANES fitNHANES fit higher
Risk of death relative to each curve's own reference value, so the two curves need not cross 1 at the same point. The dotted vertical line marks the NHANES median.
Serum Ferritin by age and sex
Each bar runs from the 5th to the 95th percentile, the darker part from the 25th to the 75th, and the tick is the median. Not a reference range or a target.
The percentiles as a table
| Sex | Age | 5th | 25th | Median | 75th | 95th | n | Cycle / source |
|---|---|---|---|---|---|---|---|---|
| All | 20-39 | 11.0 | 38.1 | 87.3 | 166 | 373 | 1,439 | NHANES 2017-2018 |
| All | 40-59 | 14.6 | 64.0 | 118 | 215 | 439 | 1,571 | NHANES 2017-2018 |
| All | 60+ | 23.7 | 63.6 | 114 | 195 | 478 | 1,914 | NHANES 2017-2018 |
| All | all | 15.1 | 52.2 | 106 | 191 | 415 | 4,924 | NHANES 2017-2018 |
| Men | 20-39 | 39.7 | 103 | 160 | 232 | 457 | 691 | NHANES 2017-2018 |
| Men | 40-59 | 44.9 | 112 | 184 | 293 | 527 | 736 | NHANES 2017-2018 |
| Men | 60+ | 23.0 | 74.0 | 143 | 246 | 591 | 969 | NHANES 2017-2018 |
| Men | all | 35.2 | 96.6 | 161 | 267 | 525 | 2,396 | NHANES 2017-2018 |
| Women | 20-39 | 7.93 | 22.2 | 42.4 | 72.4 | 139 | 748 | NHANES 2017-2018 |
| Women | 40-59 | 10.3 | 37.4 | 74.1 | 129 | 287 | 835 | NHANES 2017-2018 |
| Women | 60+ | 24.4 | 53.5 | 95.7 | 158 | 384 | 945 | NHANES 2017-2018 |
| Women | all | 10.9 | 33.9 | 68.6 | 120 | 277 | 2,528 | NHANES 2017-2018 |
What studies found when this marker was changed
They describe what happened in those study groups, not a recommendation. See all catalogued interventions.
Measured changes in Serum Ferritin, study by study
3 effects with a numeric size, each from one study arm: the dot is the reported change, the line its 95% interval where one was given. Green points move the marker the way lower risk of death lies; amber the other way. Study results in the groups studied, not predictions for a person.
| Type | Intervention | Reported effect | Evidence | Source |
|---|---|---|---|---|
| behavioral | Therapeutic phlebotomy / Blood donation in iron overload states | Weekly phlebotomy lowered ferritin from median 504 ng/mL to <100 ng/mL after a median 7.5 phlebotomies (66.5 days) | RCT | Infanti L, et al. Blood donation for iron removal in individuals with HFE… |
| clinical | Therapeutic phlebotomy / venesection (RCT in NAFLD) | Phlebotomy lowered ferritin by 148 ng/mL over 6 months vs 38 ng/mL in controls (P < 0.001) | RCT | Adams LA, et al. The impact of phlebotomy in nonalcoholic fatty liver disease… |
| diet | Dietary restriction of heme iron and red meat intake | Red meat >=7 vs <=4 servings/wk associated with higher odds of high iron stores (OR 3.61; 95% CI 1.57, 8.27); observational | cross-sectional | Fleming DJ, et al. Am J Clin Nutr. 2002;76:1375-1384. |
| diet | Individual dietary counselling to eat more flesh foods/heme iron and vitamin C, cook in cast iron, and cut phytate and calcium intake, for 16 weeks in young women with non-anaemic iron deficiency | Serum ferritin 26% higher than placebo after 16 weeks of dietary change (P=0.068), vs +59% with 50 mg/day iron amino-acid chelate | RCT | Heath AL, Skeaff CM, O'Brien SM, et al. Can dietary treatment of non-anemic… |
| nutraceutical | Oral iron supplementation (athletes; greatest effect from iron-deficient baseline) | Increased serum ferritin vs control (SMD 1.27, 95% CI 0.44-2.10); effect evident when baseline ferritin ≤ 12 µg/l | meta-analysis | Šmid AN, et al. Effects of Oral Iron Supplementation on Blood Iron Status in… |
| pharmacologic | Luspatercept 1.00-1.25 mg/kg for at least 48 weeks plus best supportive care in adults with transfusion-dependent beta-thalassaemia (BELIEVE) | Least-squares mean serum ferritin 348 ug/L lower than placebo at week 48 (95% CI 179-517) through reduced transfusion burden | RCT | Cappellini MD, Viprakasit V, Taher AT, et al. A Phase 3 Trial of Luspatercept… |
Things that worsen it
| Type | Condition or exposure | Reported effect | Evidence | Source |
|---|---|---|---|---|
| clinical | Genetic Hemochromatosis (HFE C282Y mutation homozygosity) | Most C282Y homozygotes have elevated serum ferritin; male homozygotes with ferritin of 1000 ug/L or more reported more fatigue and liver disease | prospective cohort | Allen KJ, et al. Iron-overload-related disease in HFE hereditary… |
| nutraceutical | Chronic iron supplementation (30 mg/day or more) in older adults | Supplemental iron of 30 mg/d or more associated with higher risk of high iron stores (serum ferritin >300 ug/L men, >200 ug/L women) vs nonusers (OR 4.32) in adults aged 68-93 | cross-sectional | Fleming DJ, et al. Am J Clin Nutr. 2002;76:1375-1384. |
What else moves this marker
They describe those study groups, not an individual, and an association is not a cause.
Diseases and conditions
| What | Effect on the marker | Comparison · population | Source |
|---|---|---|---|
| ↑ Polycystic ovary syndrome · Serum ferritin in women with PCOS vs healthy women | SMD +1.05 (95% CI 0.25 to 1.86) | PCOS vs healthy controls · 21 cross-sectional/case-control studies; 2,173 women with PCOS and 1,897 healthy women (all elements) | meta analysis · PMID 33042025 |
Sources
- Risk curve: Ellervik C 2014 (PMID 25156997): all-cause HR 1.5 (1.2-1.8) ferritin >=600 vs <200 ug/L. Scaled to US values (NHANES).
- Ellervik C, Marott JL, Tybjærg-Hansen A, Schnohr P, Nordestgaard BG. Total and cause-specific mortality by moderately and markedly increased ferritin concentrations: general population study and metaanalysis. Clin Chem. 2014;60(11):1419-28.
- NHANES curve: our Cox model adjusted for age and sex, NHANES 1999–2018 with linked mortality to 2019.
Map Serum Ferritin against another biomarker.
Related markers: Alpha-1-Antichymotrypsin (AACT) · Alpha-1-Antitrypsin (AAT) · Antinuclear Antibodies (ANA) · CD4:CD8 T-Cell Ratio · CD8+ T-Cell Count · Erythrocyte Sedimentation Rate (ESR) · Fibrinogen · Growth Differentiation Factor-15 (GDF-15)